Similar articles

• Neurotropic and pituitary effects of melanostatin (MIF), thyroliberin (TRH) and structurally related peptides.

  Björkman S. Björkman S. Acta Pharm Suec. 1980;17(6):352. Acta Pharm Suec. 1980. PMID: 6111892 No abstract available.
• Thyrotropin releasing hormone and its analogues I. New syntheses and biological properties of TRH (Pro-NH-NH2)3-TRH and (2-Picolyl)-TRH.

  Bobrowska J, Leroux P, Maliński E, Przybylski J, Szafranek J, Tonon MC, Vaudry H, Kupryszewski G. Bobrowska J, et al. Mater Med Pol. 1980 Jan-Jun;12(1-2):129-35. Mater Med Pol. 1980. PMID: 6799704 No abstract available.
• [The analgesic activity of TRH and MSH].

  Cuenca E, Serrano MI, Gibert-Rahola J, Carrasco MS, Esteban JM. Cuenca E, et al. Arch Farmacol Toxicol. 1978 Apr;4(1):71-6. Arch Farmacol Toxicol. 1978. PMID: 100062 Spanish. No abstract available.
• Neuropeptide effects on brain development.

  Handelmann GE. Handelmann GE. J Physiol (Paris). 1985;80(4):268-74. J Physiol (Paris). 1985. PMID: 2422355 Review.
• [Extra-hormonal aspects of the central action of thyroliberin (TRH)].

  Przegaliński E. Przegaliński E. Acta Physiol Pol. 1989;40 Suppl 34:115-26. Acta Physiol Pol. 1989. PMID: 2577310 Review. Polish. No abstract available.